{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:27:33Z","timestamp":1792747653210,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["I01CX000361"],"award-info":[{"award-number":["I01CX000361"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AA026917"],"award-info":[{"award-number":["U01 AA026917"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AA025208"],"award-info":[{"award-number":["R01AA025208"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jhep.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T17:41:48Z","timestamp":1613670108000},"page":"163-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating I\u03baB\u03b6 target genes in hepatocytes"],"prefix":"10.1016","volume":"75","author":[{"given":"Yong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonghwan","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Mackowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robim M.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeni","family":"Ait-Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthat","family":"Liangpunsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2021.02.004_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri3766","article-title":"The IL-20 subfamily of cytokines \u2013 from host defence to tissue homeostasis","volume":"14","author":"Rutz","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2021.02.004_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd4176","article-title":"Therapeutic opportunities of the IL-22-IL-22R1 system","volume":"13","author":"Sabat","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2021.02.004_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.02.004_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(01)00187-8","article-title":"Interleukin 20: discovery, receptor identification, and role in epidermal function","volume":"104","author":"Blumberg","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2021.02.004_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hep.27189","article-title":"IL-20 and IL-20R1 antibodies protect against liver fibrosis","volume":"60","author":"Chiu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.02.004_bib6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/JLB.MR1117-471R","article-title":"IL-20 receptor cytokines in autoimmune diseases","volume":"104","author":"Chen","year":"2018","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jhep.2021.02.004_bib7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3389\/fimmu.2018.01373","article-title":"The interleukin-20 cytokines in intestinal diseases","volume":"9","author":"Niess","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2021.02.004_bib8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3389\/fimmu.2018.01155","article-title":"The interleukin-20 cytokine family in liver disease","volume":"9","author":"Caparros","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2021.02.004_bib9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ni.2637","article-title":"Signaling via the IL-20 receptor inhibits cutaneous production of IL-1beta and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus","volume":"14","author":"Myles","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2021.02.004_bib10","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI0215841","article-title":"Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS","volume":"110","author":"Hong","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.jhep.2021.02.004_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41423-020-00580-w","article-title":"Immunopathobiology and therapeutic targets related to cytokines in liver diseases","volume":"18","author":"He","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhep.2021.02.004_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature02738","article-title":"Regulation of Toll\/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta","volume":"430","author":"Yamamoto","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2021.02.004_bib13","doi-asserted-by":"crossref","first-page":"E5825","DOI":"10.1073\/pnas.1509971112","article-title":"IkappaBzeta is a key driver in the development of psoriasis","volume":"112","author":"Johansen","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.02.004_bib14","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.4049\/jimmunol.176.9.5559","article-title":"IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta","volume":"176","author":"Cowland","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2021.02.004_bib15","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.4049\/jimmunol.1300089","article-title":"IkappaBzeta is a transcriptional key regulator of CCL2\/MCP-1","volume":"190","author":"Hildebrand","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2021.02.004_bib16","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.1073\/pnas.1801377115","article-title":"IkappaBzeta is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes","volume":"115","author":"Muller","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.02.004_bib17","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.micinf.2014.08.005","article-title":"Transcriptional regulation of CCL20 expression","volume":"16","author":"Zhao","year":"2014","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jhep.2021.02.004_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2016.07.015","article-title":"S100A8\/A9: from basic science to clinical application","volume":"167","author":"Pruenster","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jhep.2021.02.004_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/hep.27447","article-title":"Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6\/STAT3","volume":"61","author":"Xu","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.02.004_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/cmi.2015.97","article-title":"Hepatocytes: a key cell type for innate immunity","volume":"13","author":"Zhou","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhep.2021.02.004_bib21","doi-asserted-by":"crossref","first-page":"pe1","DOI":"10.1126\/stke.11pe1","article-title":"Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation","volume":"1","author":"Natoli","year":"2008","journal-title":"Sci Signal"},{"key":"10.1016\/j.jhep.2021.02.004_bib22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.5483\/BMBRep.2015.48.11.190","article-title":"Implications of NQO1 in cancer therapy","volume":"48","author":"Oh","year":"2015","journal-title":"BMB Rep"},{"key":"10.1016\/j.jhep.2021.02.004_bib23","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1084\/jem.20172024","article-title":"NQO1 inhibits the TLR-dependent production of selective cytokines by promoting IkappaB-zeta degradation","volume":"215","author":"Kimura","year":"2018","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhep.2021.02.004_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2567.2009.03054.x","article-title":"The aryl hydrocarbon receptor: a perspective on potential roles in the immune system","volume":"127","author":"Stevens","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jhep.2021.02.004_bib25","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/hep.29919","article-title":"Hepatocytes and neutrophils cooperatively suppress bacterial infection by differentially regulating lipocalin-2 and neutrophil extracellular traps","volume":"68","author":"Li","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.02.004_bib26","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.4049\/jimmunol.170.10.5252","article-title":"C-C chemokine ligand 2\/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse","volume":"170","author":"Ajuebor","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2021.02.004_bib27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4049\/jimmunol.172.1.398","article-title":"Essential contribution of monocyte chemoattractant protein-1\/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia","volume":"172","author":"Amano","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2021.02.004_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1183\/09031936.00183814","article-title":"Myeloid-related protein-14 deficiency promotes inflammation in staphylococcal pneumonia","volume":"46","author":"Achouiti","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhep.2021.02.004_bib29","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1172\/JCI130546","article-title":"S100A8\/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis","volume":"130","author":"Scott","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2021.02.004_bib30","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.4049\/jimmunol.1700253","article-title":"IL-20 signaling in activated human neutrophils inhibits neutrophil migration and function","volume":"198","author":"Gough","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2021.02.004_bib31","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/nature08922","article-title":"IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors","volume":"464","author":"Okamoto","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2021.02.004_bib32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0891-5849(00)00306-3","article-title":"Regulation of genes encoding NAD(P)H:quinone oxidoreductases","volume":"29","author":"Jaiswal","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2021.02.004_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1101\/gad.319905","article-title":"A\u00a0mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73","volume":"19","author":"Asher","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2021.02.004_bib34","doi-asserted-by":"crossref","first-page":"13593","DOI":"10.1038\/ncomms13593","article-title":"NQO1 inhibits proteasome-mediated degradation of HIF-1alpha","volume":"7","author":"Oh","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2021.02.004_bib35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jhep.2021.02.004_bib36","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.28456","article-title":"Interleukin-1 and inflammasomes in alcoholic liver disease\/acute alcoholic hepatitis and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"64","author":"Tilg","year":"2016","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821001045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821001045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:10:18Z","timestamp":1778674218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827821001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0168827821001045"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.02.004","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating I\u03baB\u03b6 target genes in hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}